Weifa ASA : Third quarter 2015 results
(Thomson Reuters ONE) -
Oslo, 28 October 2015
Weifa ASA: Third quarter 2015 results
Weifa ASA (OSE: WEIFA) maintained high market share in all key segments during
third quarter 2015, and delivered continued good operations. Total revenues for
the quarter amounted to NOK 77.0 million, in line with consumer health revenues
for the year earlier period. It was the first full quarter as a pure consumer
health company following the spin-off of its B2B operations and tablet
manufacturing in the second quarter of 2015.
EBITDA was NOK 16.9 million, before NOK 1.8 million in the calculated cost of
employee options, corresponding to an adjusted EBITDA margin of 21.9 percent.
Total consumer health revenues in the first nine months of 2015 were NOK 235
million, representing an increase of approximately 5 percent from the same
period last year. Nine-month EBITDA came to NOK 48.5 million before option cost
of NOK 4.9 million, corresponding to an adjusted EBITDA margin of 20.6 percent.
"Weifa is on track to deliver revenue growth and improved EBITDA margin in
2015. We are satisfied with our first quarter as a pure consumer health company,
maintaining a high market share in our key categories and continuing our track-
record for innovation by introducing Bronkyl forte to drive growth in the cough
and cold segment", says CEO Kathrine Gamborg Andreassen.
Weifa will give a presentation today at 08:30 CET at Felix Konferansesenter,
Bryggetorget 3, Oslo, Norway. CEO Kathrine Gamborg Andreassen and CFO Simen
Nyberg-Hansen will represent the company. The presentation will also be webcast
live and can be accessed directly from:
http://webtv.hegnar.no/presentation.php?webcastId=25254877
http://www.weifa.no/Investor
Please find the report and presentation for the third quarter enclosed. The
report and presentation will also be made available on www.weifa.no.
For further information, please contact:
Kathrine Gamborg Andreassen
CEO
+47 95 17 86 80
kathrine.gamborg.andreassen(at)weifa.no
Simen Nyberg-Hansen
CFO
+47 98 20 63 55
Simen.nyberg-hansen(at)weifa.no
Weifa is Norway's leading consumer health company. We supply real value through
medicines, lifestyle products and solutions that address the essential needs of
consumers, customers and professional partners. Weifa was founded in 1940 and
now employs about 30 highly qualified people at our headquarters in Oslo. The
company has a strong position in Norway and is the market leader in pain relief,
with well-established brands such as Paracet and Ibux. We are also present in
other key areas such as dietary supplements and treatment for colds and
respiratory problems. Weifa is listed on the Oslo Børs (ticker WEIFA). For
further information, please visit: www.weifa.no
This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
Weifa ASA 3rd quarter report 2015:
http://hugin.info/136972/R/1961765/715384.pdf
Weifa ASA 3rd quarter presentation 2015:
http://hugin.info/136972/R/1961765/715385.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Weifa ASA via GlobeNewswire
[HUG#1961765]
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
" alt="Endeavour Silver Announces Revised Date for Release of Third Quarter, 2015 Financial ResultsDatum: 28.10.2015 - 08:00 Uhr
Sprache: Deutsch
News-ID 429986
Anzahl Zeichen: 3961
contact information:
Town:
Oslo
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 228 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Weifa ASA : Third quarter 2015 results"
steht unter der journalistisch-redaktionellen Verantwortung von
Weifa ASA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
